Inactive Instrument

Meda AB Share Price

Stocks

SE0000221723

Pharmaceuticals

End-of-day quote Nasdaq Stockholm
- ^SEK	-

20/16/20	Meda : Mylan gets EU approval for Meda purchase, subject to conditions	RE
15/16/15	Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	RE

Latest news: Meda AB

20/16/20	Meda : Mylan gets EU approval for Meda purchase, subject to conditions	RE
15/16/15	Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	RE
02/16/02	Meda : EU regulators to rule on Mylan's $7.2 billion Meda bid by July 6	RE
09/16/09	Valeant Pharmaceuticals Intl : gives Pershing Square one board seat, adds two other directors	RE
11/16/11	Abbott Laboratories : Mylan to buy Swedish drugmaker Meda in $7.2 billion deal	RE
15/16/15	Meda : Swedish drug firm Meda nears deal to sell U.S. business - sources	RE
14/14/14	AbbVie : Shire ready to bow to AbbVie's increased $53 billion offer	RE
12/14/12	Abbott Laboratories : Mylan near multibillion-dollar deal for Abbott drug assets - sources	RE
12/14/12	Abbott Laboratories : Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets - sources	RE
15/14/15	Banks vie for fees as Nordic deal scene ignites	RE
06/14/06	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/14/06	Actavis : M&A frenzy in healthcare sector	RE
01/14/01	Actavis : Pfizer's designs on AstraZeneca stir tax envy among rivals	RE

Press Releases: Meda AB

25/16/25	Meda : Bulletin from the Extraordinary General Meeting in Meda AB (publ)	BU
08/16/08	Meda : Delisting of Meda Aktiebolag (publ)	BU
05/16/05	MEDA: Notice to noteholders regarding change of control	BU
02/16/02	Meda : Aktiebolag (publ) applies for delisting and convenes an extraordinary general meeting	BU
02/16/02	Meda : Extraordinary General Meeting of Meda Aktiebolag (publ)	BU

More press releases

News in other languages: Meda AB

20/16/20	Mylan NV : La CE autorise Mylan à racheter Meda sous conditions
15/16/15	Meda : L'UE devrait accepter le rachat de Meda par Mylan-sources
11/16/11	Cisco Systems : Wall Street ouvre en net recul
11/16/11	Wall Street ouvre en baisse, craintes sur la croissance mondiale
11/16/11	Meda : BOURSE-Meda s'envole de plus de 70% après son rachat par Mylan

Managers and Directors: Meda AB

Manager	Title	Age	Since
Lars Henrik Andreas Rejnus CEO	Chief Executive Officer	52	-
Mårten Österlund LAW	General Counsel	69	09/12/2014
Rainer Weiss CTO	Chief Tech/Sci/R&D Officer	64	01/01/2005

Director	Title	Age	Since
Colleen Ostrowski BRD	Director/Board Member	53	25/08/2016
Caroline Rebecca Louise Dixon BRD	Director/Board Member	58	25/08/2016
Lars Henrik Andreas Rejnus CHM	Chairman	52	-

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ELI LILLY AND COMPANY	+0.11%	+1.71%	+63.08%	+117.61%	1,05500Cr
	JOHNSON & JOHNSON	+0.27%	+0.92%	+49.74%	+73.35%	65TCr
	ABBVIE INC.	+0.73%	+0.68%	+19.32%	+74.90%	47TCr
	ROCHE HOLDING AG	-1.36%	-0.39%	+40.20%	+41.03%	35TCr
	NOVARTIS AG	+1.34%	+5.47%	+23.37%	+31.30%	27TCr
	ASTRAZENECA PLC	-0.48%	-0.06%	+13.56%	+12.36%	26TCr
	AMGEN INC.	+0.85%	+6.35%	+52.62%	+54.39%	22TCr
	GILEAD SCIENCES, INC.	+0.85%	+1.10%	+35.15%	+101.82%	19TCr
	NOVO NORDISK A/S	-0.30%	-10.41%	-27.62%	-61.04%	17TCr
	Average	+0.35%	+0.74%	+29.94%	+49.52%	40.43TCr
	Weighted average by Cap.	+0.32%	+1.32%	+40.03%	+69.79%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

As early as today, start finding the best investment opportunities!